Head to head

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

Head to head

Postby bromley » Thu May 11, 2006 8:29 am

The following story is from the Boston Cure Project today.

One has to agree with Art's comment at the end.

Ian

"A two year open-label study comparing Betaseron (called Betaferon in Europe) and Avonex found no substantial differences in relapse rates, time to first relapse, progression of disability, and neutralizing antibody development".

Can we stop spending money on studies of the existing drugs and start looking at some new ones, now?"
User avatar
bromley
Family Elder
 
Posts: 1887
Joined: Fri Sep 10, 2004 3:00 pm

Advertisement

Re: Head to head

Postby HarryZ » Thu May 11, 2006 4:41 pm

Ian,

Can we stop spending money on studies of the existing drugs and start looking at some new ones, now?"


These companies have no interest in getting into the deep research required in finding a cause for MS and thus possibly a cure. The ONLY reason you see them doing these head to head trials is to attempt to gain a few percent increase in the market share of the current "approved" therapies for MS. Just a few percent gain means millions in increased revenue. This is strictly business and has little if anything to do with the health concern of MS patients.

Harry
User avatar
HarryZ
Family Elder
 
Posts: 2445
Joined: Tue May 25, 2004 3:00 pm
Location: London, ON, Canada


Return to General Discussion

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users